Skip to content

Bright Light Therapy for Individuals With Dementia

Bright Light Therapy for Individuals With Dementia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02800850
Enrollment
71
Registered
2016-06-15
Start date
2013-07-31
Completion date
2014-07-31
Last updated
2016-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Keywords

Dementia, Depression, Agitation, Bright Light

Brief summary

Many older adults with dementia living in long-term care facilities experience depression and agitation, which cause angst and personal suffering. Prior to this research, evidence was inconclusive but indicated that bright light exposure may reduce depression and agitation in long-term care residents with dementia. The purpose of this study was to determine if the degree of improvement in depression and agitation scores over the course of eight weeks was significantly greater in persons with dementia receiving bright light exposure than in persons with dementia receiving placebo light exposure. Sixty individuals participated in the study, with 30 in the bright light group and 30 in the low level light group.

Interventions

BEHAVIORALBright Light
BEHAVIORALPlacebo Light

Sponsors

Commonwealth Care of Roanoke, Inc.
CollaboratorUNKNOWN
Virginia Center on Aging (ARDRAF)
CollaboratorUNKNOWN
Radford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

were age 60 or older; diagnosis of dementia; ophthalmology screening indicating that the individual was able to perceive light and did not have cataracts, glaucoma, macular degeneration, or retinal problems; able to sit up and keep eyes open; and not too restless to sit for 30 minutes.

Exclusion criteria

were age 59 or younger; no diagnosis of dementia; presence of cataracts, glaucoma, macular degeneration, or retinal problems; unable to sit up and keep eyes open; and too restless to sit for 30 minutes.

Design outcomes

Primary

MeasureTime frame
Depressive Symptom Assessment for Older AdultsAfter the eight-week experiment
Cohen-Mansfield Agitation Inventory (Frequency)After the eight-week experiment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026